Cargando…

Molecular Mechanisms Underlying the Role of MicroRNAs in the Chemoresistance of Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is an extremely severe disease where the mortality and incidence rates are almost identical. This is mainly due to late diagnosis and limited response to current treatments. The tumor macroenvironment/microenvironment have been frequently reported as the major...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garajová, Ingrid, Le Large, Tessa Y., Frampton, Adam E., Rolfo, Christian, Voortman, Johannes, Giovannetti, Elisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4163377/ https://www.ncbi.nlm.nih.gov/pubmed/25250326 http://dx.doi.org/10.1155/2014/678401

Ejemplares similares

Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer
por: Comandatore, Annalisa, et al.
Publicado: (2022)

MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma—a step towards personalized therapy
por: Garajová, Ingrid, et al.
Publicado: (2015)

Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer
por: Hwang, Jin-Hyeok, et al.
Publicado: (2010)

microRNAs in cancer chemoresistance: The sword and the shield
por: Mondal, Priya, et al.
Publicado: (2021)

Unravelling the Diagnostic Dilemma: A MicroRNA Panel of Circulating MiR-16 and MiR-877 as A Diagnostic Classifier for Distal Bile Duct Tumors
por: Meijer, Laura L., et al.
Publicado: (2019)

Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood Biomarkers
por: Boyd, Lenka N. C., et al.
Publicado: (2023)

microRNAs: An Emerging Paradigm in Lung Cancer Chemoresistance
por: Naidu, Srivatsava, et al.
Publicado: (2015)

Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance
por: Ayers, Duncan, et al.
Publicado: (2017)

The implication of liquid biopsies to predict chemoresistance in pancreatic cancer
por: Pietri, Elisabetta, et al.
Publicado: (2021)

MicroRNAs: short non-coding players in cancer chemoresistance
por: Donzelli, Sara, et al.
Publicado: (2014)

MicroRNAs as Potential Biomarkers for Chemoresistance in Adenocarcinomas of the Esophagogastric Junction
por: Just, Christina, et al.
Publicado: (2019)

MicroRNAs in Cancer Management: Big Challenges for Small Molecules
por: Gandellini, Paolo, et al.
Publicado: (2015)

microRNAs and Acute Myeloid Leukemia Chemoresistance: A Mechanistic Overview
por: Gabra, Martino Marco, et al.
Publicado: (2017)

Plasma microRNAs Predict Chemoresistance in Patients With Metastatic Breast Cancer
por: Shao, Bin, et al.
Publicado: (2019)

Epithelial-Mesenchymal Transition and MicroRNAs in Colorectal Cancer Chemoresistance to FOLFOX
por: Escalante, Paula I., et al.
Publicado: (2021)

“Open Sesame?”: Biomarker Status of the Human Equilibrative Nucleoside Transporter-1 and Molecular Mechanisms Influencing its Expression and Activity in the Uptake and Cytotoxicity of Gemcitabine in Pancreatic Cancer
por: Randazzo, Ornella, et al.
Publicado: (2020)

Overview of microRNAs as liquid biopsy biomarkers for colorectal cancer sub-type profiling and chemoresistance
por: Buhagiar, Alfred, et al.
Publicado: (2021)

MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance
por: Park, Young Tae, et al.
Publicado: (2013)

MicroRNAs in Hepatobiliary and Pancreatic Cancers
por: Saito, Yoshimasa, et al.
Publicado: (2011)

Genome-wide profiles of methylation, microRNAs, and gene expression in chemoresistant breast cancer
por: He, Dong-Xu, et al.
Publicado: (2016)

Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data
por: Wang, Ya-Wen, et al.
Publicado: (2018)

Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review
por: Loren, Pía, et al.
Publicado: (2022)

A comprehensive survey into the role of microRNAs in ovarian cancer chemoresistance; an updated overview
por: Saburi, Ahmad, et al.
Publicado: (2022)

MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors
por: Jiao, Long R., et al.
Publicado: (2012)

The expression and functions of microRNAs in pancreatic adenocarcinoma and hepatocellular carcinoma
por: Li, Wei, et al.
Publicado: (2011)

c-Met as a Target for Personalized Therapy
por: Garajová, Ingrid, et al.
Publicado: (2015)

MicroRNAs in pancreatic cancer diagnosis and therapy
por: Słotwiński, Robert, et al.
Publicado: (2018)

The Role of MicroRNAs in Pancreatitis Development and Progression
por: Patel, Hetvi R., et al.
Publicado: (2023)

The role of miRNAs in the diagnosis, chemoresistance, and prognosis of pancreatic ductal adenocarcinoma
por: Ren, Le, et al.
Publicado: (2018)

MicroRNAs contribute to ATP-binding cassette transporter- and autophagy-mediated chemoresistance in hepatocellular carcinoma
por: Espelt, María V, et al.
Publicado: (2019)

A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease
por: Mato Prado, Mireia, et al.
Publicado: (2023)

Network of microRNAs-mRNAs Interactions in Pancreatic Cancer
por: Naderi, Elnaz, et al.
Publicado: (2014)

The Role of Circular RNAs in Pancreatic Ductal Adenocarcinoma and Biliary-Tract Cancers
por: Limb, Christopher, et al.
Publicado: (2020)

MicroRNA-1246 expression associated with CCNG2-mediated chemoresistance and stemness in pancreatic cancer
por: Hasegawa, S, et al.
Publicado: (2014)

Fungal mycobiome-mediated immune response: a non-negligible promoter in pancreatic oncogenesis and chemoresistance
por: Jiang, Yaling, et al.
Publicado: (2023)

More than a Bubble: Extracellular Vesicle microRNAs in Head and Neck Squamous Cell Carcinoma
por: Panvongsa, Wittaya, et al.
Publicado: (2022)

The Role of microRNAs in the Diagnosis and Treatment of Pancreatic Adenocarcinoma
por: Diab, Maria, et al.
Publicado: (2016)

MicroRNAs as potential therapeutic targets for pancreatic cancer
por: Chu, Xiangyu, et al.
Publicado: (2022)

Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer
por: Wang, Jin, et al.
Publicado: (2014)

High-Throughput MicroRNA (miRNAs) Arrays Unravel the Prognostic Role of MiR-211 in Pancreatic Cancer
por: Giovannetti, Elisa, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_3fnslnap1ffu9kq6atml1n385r